From Traditional European Medicine to Discovery of New Drug Candidates for the Treatment of Dementia and Alzheimer's Disease: Acetylcholinesterase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|8|976-983

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.8, 2013-03, pp. : 976-983

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer’s disease: do we need new inhibitors?

By Small David H  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 817-825

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Inhibitors of &bgr;-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1820-1842

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 2, 2011-03 ,pp. : 239-250

Bentham Science Publishers

Access to resources Recommend Favorite